Mainstay Capital Management’s Chemours CC Stock Holding History

Mainstay Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-52,560	Closed	-$1.68M	–	100
2022 Q2	$1.68M	Buy	52,560 +785	+2%	+$28.9K	0.39%	23
2022 Q1	$1.63M	Buy	51,775 +21,790	+73%	+$682K	0.3%	34
2021 Q4	$1.01M	Buy	+29,985	New	+$934K	0.3%	60
2018 Q4	–	Sell	-183	Closed	-$7K	–	133
2018 Q3	$7K	Buy	+183	New	+$8.01K	﹤0.01%	360
2018 Q1	–	Sell	-400	Closed	-$20K	–	339
2017 Q4	$20K	Buy	+400	New	+$21K	0.02%	220

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mainstay Capital Management's CC Position: Q3 2022 in Review

Mainstay Capital Management sold out of Chemours (CC) in Q3 2022, closing a stake of 52,560 shares — an estimated $1.68M sold.

Mainstay Capital Management first reported a position in CC in Q4 2017 and held it in 5 quarters. The position peaked at $1.68M in Q2 2022. 487 funds tracked by Wall St. Rank hold CC as of Q3 2022.

Mainstay Capital Management reported no remaining Chemours position as of Q3 2022 after selling out during the quarter.
Mainstay Capital Management sold 52,560 Chemours shares in Q3 2022, an estimated $1.68M.
Mainstay Capital Management first reported a position in Chemours in Q4 2017 and held it in 5 quarters.
Mainstay Capital Management's Chemours position peaked at $1.68M in Q2 2022.
487 funds tracked by Wall St. Rank held Chemours as of Q3 2022.

Based on Mainstay Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.